Recently, a real-world study showing association between incretin-based therapy and changes in taste perception with GLP-1 or dual GLP-1/GIP-RAs usage for around 40 weeks reported that independently to weight loss, there was an increase in sweet perception intensity up to 4.7 times and salt perception up to 3.2 times in around 20% of the participants, resulting as well in earlier satiety, and reduction of hunger and craving due to a major sensibilization to both flavors with any of these medication, although they did not mention further impact in weight loss or BMI change (170)
Keep vials, syringes, needles, and medicines out of reach of children
For information about what happens after stopping, including how long side effects persist, see our guide to how long semaglutide stays in your system
The card is not working
Visual indicators include color change (from blue to green, brown, or cloudy), visible particles or precipitation, and unusual film or residue
Dose Holidays